This report aims to illustrate the effects of rituximab therapy on cavin-4 immunoglobulin G rippling muscle disease.
Case report of a 65-year-old man
Administration of rituximab therapy
Monitoring clinical outcomes post-treatment.
The patient achieved complete remission of rippling muscle disease
Significant improvement in muscle function and symptoms noted after therapy.
Abstract
This case report describes a 65-year-old man who experienced complete remission of cavin-4 immunoglobulin G (IgG) rippling muscle disease after receiving rituximab therapy.